Atropinized patients agitations
Reading File
Finding Sources
Finding Sources
Searching PubMed
atropine agitation anticholinergic toxicity management
Reading File
Reading File
Reading File
Excellent - I now have all the content needed for a thorough answer.
Agitation in Atropinized Patients
Mechanism
Atropine (and other anticholinergic agents) block muscarinic (M1, M2, M3) receptors. At therapeutic doses, CNS effects are minimal. However, at toxic or high doses, blockade of central muscarinic receptors produces CNS excitation rather than sedation, because the normal cholinergic "braking" on neuronal excitability is lost.
"In toxic doses, scopolamine, and to a lesser degree atropine, can cause excitement, agitation, hallucinations, and coma." - Katzung's Basic and Clinical Pharmacology, 16th Ed.
Scopolamine crosses the blood-brain barrier more readily than atropine, so it produces central effects at lower doses. Atropine generally requires supratherapeutic doses to produce marked CNS toxicity.
Clinical Picture - Anticholinergic Toxidrome
The full picture follows the classic mnemonic "Hot as a hare, Blind as a bat, Dry as a bone, Red as a beet, Mad as a hatter":
| Feature | Mechanism |
|---|---|
| Agitation, delirium, hallucinations | Central M1 blockade |
| Tachycardia | Cardiac M2 blockade |
| Dry flushed skin ("atropine flush") | Loss of sweat and vasomotor tone |
| Hyperthermia ("atropine fever") | Inability to sweat + increased motor activity |
| Mydriasis, cycloplegia | Iris/ciliary M3 blockade |
| Urinary retention, ileus | Smooth muscle M3 blockade |
| Dry mouth | Salivary gland M3 blockade |
From the Washington Manual: "Anticholinergic toxidrome - agitation with delirium, hallucinations, picking at surroundings..." - a pattern often described as "mumbling delirium with picking behavior."
"Agitation and delirium are not unusual in older adult patients." - Morgan & Mikhail's Clinical Anesthesiology, 7e
Postoperative Context
In the PACU (post-anesthesia care unit), agitation from central anticholinergic drugs (atropine, scopolamine) is part of the differential for postoperative restlessness. Before attributing agitation to anticholinergic excess, the following must be excluded:
- Hypoxemia / respiratory acidosis (most important)
- Metabolic acidosis
- Hypotension
- Bladder distention
- Pain (most common cause of post-op agitation)
- Surgical complications (e.g., occult hemorrhage)
- Other drug effects (phenothiazines, ketamine)
Management
1. Physostigmine (First-Line Reversal)
Physostigmine is a reversible acetylcholinesterase inhibitor that crosses the blood-brain barrier. By preventing ACh breakdown, it restores cholinergic tone at central muscarinic receptors - directly reversing the agitation and delirium.
Dose:
- Adults: 1-2 mg IV over 5 minutes
- Children: 0.05 mg/kg IV
"Physostigmine, 1 to 2 mg intravenously (0.05 mg/kg in children), is most effective in treating delirium due to atropine and scopolamine." - Morgan & Mikhail's Clinical Anesthesiology, 7e
"In adult patients who have obvious central anticholinergic delirium with agitation, we use physostigmine 1 to 2 mg IV, infused over 5 minutes in the absence of contraindications." - Rosen's Emergency Medicine
Duration of effect: Typically 45-60 minutes. Delirium recurs in 30-90% of responders (repeat dosing or infusion may be needed).
Contraindications to physostigmine:
- Reactive airway disease / asthma
- Cardiovascular disease: bradycardia, heart block, intraventricular conduction delay (QRS widening)
- Active seizures (may precipitate further seizures)
2. Benzodiazepines (Symptomatic / When Toxidrome Unclear)
- Midazolam: 0.5-1 mg IV (0.05 mg/kg in children) - intermittent doses for persistent agitation
- Lorazepam: 1-2 mg IV every 10-15 minutes titrated to mild sedation - use when the toxidrome is unclear or physostigmine is contraindicated
"The use of physostigmine for reversal of anticholinergic delirium does not preclude the use of benzodiazepines for agitation and vice versa." - Rosen's Emergency Medicine
3. Physical Restraints
For marked agitation posing risk of self-injury (especially in children), arm and leg restraints may be necessary while pharmacological treatment is initiated.
Key Summary Table
| Scenario | Preferred Approach |
|---|---|
| Confirmed anticholinergic agitation/delirium | Physostigmine 1-2 mg IV |
| Toxidrome unclear, agitated delirium | Lorazepam 1-2 mg IV q 10-15 min |
| Physostigmine contraindicated | Midazolam or lorazepam |
| Pediatric post-op agitation (post atropine) | Physostigmine 0.05 mg/kg IV |
| Mild post-op agitation, pain excluded | Reassurance + midazolam 0.5-1 mg IV |
Key teaching point: Physostigmine is the specific antidote for anticholinergic agitation/delirium, but only use it when the anticholinergic toxidrome is clearly identified and contraindications are absent. Benzodiazepines remain the safer choice when the clinical picture is ambiguous.
Sources: Katzung's Basic & Clinical Pharmacology 16e; Morgan & Mikhail's Clinical Anesthesiology 7e; Rosen's Emergency Medicine; Washington Manual of Medical Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.